Edition:
United Kingdom

People: Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

33.49USD
23 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$33.49
Open
$31.68
Day's High
$33.85
Day's Low
$31.55
Volume
124,927
Avg. Vol
166,912
52-wk High
$54.45
52-wk Low
$27.85

Koppikar, Utpal 

Mr. Utpal Koppikar was Chief Financial Officer of the Company. Most recently, Mr. Koppikar held several senior financial leadership positions at Gilead Sciences, including as Vice President of Corporate and Operations Finance and as Vice President of Finance Europe, Middle East and Australia. Prior to Gilead, he served in multiple finance roles of increasing responsibility at Amgen. He began his career at Honeywell Aerospace (formerly AlliedSignal). Mr. Koppikar earned his B.S. in aerospace engineering at the University of Maryland and received a M.S. in aeronautical and astronautical engineering from Stanford University. He also holds an MBA in finance and marketing from UCLA Anderson School of Management.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Isaac Ciechanover

3,366,820

Utpal Koppikar

--

Joseph Newell

1,641,820

Christopher Haqq

3,298,020

Mitchall Clark

1,402,910

Gad Soffer

3,098,040
As Of  31 Dec 2017